antimicrobial resistance

News

Shionogi puts up to $600m behind BioVersys antibiotics

Shionogi has added to its antibiotics pipeline by taking an option on a preclinical-stage candidate from BioVersys for non-tuberculous mycobacteria.

News

Wockhardt has high hopes for novel antibiotic Zaynich

Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.

News

Data sets up filing of new GSK antibiotic this year

GSK has said it will file its oral carbapenem antibiotic tebipenem HBr for approval before the end of this year as a treatment for complicated UTIs.

Market Access

Reuters Europe 2025: Using value propositions to improve acc...

In a Reuters Pharma Europe 2025 fireside chat, NICE Advice Director Brad Grove spoke with Novartis's Matic Meglic about novel pharma payment models.

R&D

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference

News

FDA clears new antibiotic for superbug infections

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

Shionogi puts up to $600m behind BioVersys antibiotics

Wockhardt has high hopes for novel antibiotic Zaynich

Data sets up filing of new GSK antibiotic this year

Reuters Europe 2025: Using value propositions to improve acc...

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

FDA clears new antibiotic for superbug infections

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

antimicrobial resistance

Editor's Picks